People analytics and organizational psychology: building a high-performance, innovative culture in the pharmaceutical...

Pharmaceutical and biotech organizations advance therapies through a sequence of interdependent stage-gates in which delays, rework, and knowledge discontinuities have outsized economic and patient consequences. Here, we argue that people strategy should be treated as an explicit pipeline-risk control. We introduce the People Analytics + Industrial-Organizational Psychology for R&D, (PA‑IOP‑R&D) framework, which fuses people analytics with organizational psychology to reduce avoidable rework, protect time-to-milestone, and preserve tacit expertise. The framework centers psychological safety (to enable learning, voice, and error reporting in high-uncertainty R&D) and the job demands-resources (JD-R) model (to calibrate resources that buffer high demands and sustain engagement); perceived organizational support provides the reciprocity mechanism that retains scarce late-career know-how. We codify governance guardrails (purpose limitation, transparency, access control, and bias/fairness review) to prevent analytic harms that would otherwise chill voice. We translate leading indicators (e.g., network bottlenecks, demand-resource imbalance, and safety climate) into tested interventions and stage gate-aligned metrics, and specify quasi-experimental evaluation to distinguish signal from noise.